Adhesion G-protein coupled receptor 56 is required for 3T3-L1 adipogenesis.
Mohammad Al HasanPoornima RoySharron DolanPatricia Esther MartinSteven PattersonChris BartholomewPublished in: Journal of cellular physiology (2019)
Obesity-associated conditions represent major global health and financial burdens and understanding processes regulating adipogenesis could lead to novel intervention strategies. This study shows that adhesion G-protein coupled receptor 56 (GPR56) gene transcripts are reduced in abdominal visceral white adipose tissue derived from obese Zucker rats versus lean controls. Immunostaining in 3T3-L1 preadipocytes reveals both mitotic cell restricted surface and low level general expression patterns of Gpr56. Gpr56 transcripts are differentially expressed in 3T3-L1 cells during adipogenesis. Transient knockdown (KD) of Gpr56 in 3T3-L1 cells dramatically inhibits differentiation through reducing the accumulation of both neutral cellular lipids (56%) and production of established adipogenesis Pparγ 2 (60-80%), C/ebpα (40-78%) mediator, and Ap2 (56-80%) marker proteins. Furthermore, genome editing of Gpr56 in 3T3-L1 cells created CW2.2.4 and RM4.2.5.5 clones (Gpr56 -/- cells) with compound heterozygous deletion frameshift mutations which abolish adipogenesis. Genome edited cells have sustained levels of the adipogenesis inhibitor β-catenin, reduced proliferation, reduced adhesion, altered profiles, and or abundance of extracellular matrix component gene transcripts for fibronectin, types I, III, and IV collagens and loss of actin stress fibers. β-catenin KD alone is insufficient to restore adipogenesis in Gpr56 -/- cells. Together these data show that Gpr56 is required for adipogenesis in 3T3-L1 cells. This report is the first demonstration that Gpr56 participates in regulation of the adipogenesis developmental program. Modulation of the levels of this protein and/or its biological activity may represent a novel target for development of therapeutic agents for the treatment of obesity.
Keyphrases
- induced apoptosis
- cell cycle arrest
- adipose tissue
- fatty acid
- crispr cas
- insulin resistance
- metabolic syndrome
- healthcare
- genome editing
- type diabetes
- public health
- signaling pathway
- randomized controlled trial
- stem cells
- weight loss
- bariatric surgery
- cell proliferation
- epithelial mesenchymal transition
- physical activity
- gene expression
- genome wide
- body composition
- early onset
- dna methylation
- escherichia coli
- big data
- copy number
- smoking cessation
- cystic fibrosis
- health insurance
- anaerobic digestion
- cell adhesion